Montavont A, Demarquay G, Ryvlin P, Rabilloud M, Guénot M, Ostrowsky K, Isnard J, Fischer C, Mauguière F
Service de neurologie fonctionnelle et d'épileptologie, hôpital neurologique, Bron.
Rev Neurol (Paris). 2007 Dec;163(12):1169-77. doi: 10.1016/S0035-3787(07)78401-1.
Vagus Nerve Stimulation (VNS) is recognized as an efficient procedure for controlling seizures in patients with drug-refractory epilepsies. It is used as a palliative procedure as a complement to conventional treatment by antiepileptic (AE) drugs and, according to literature, 40 to 50p.cent of patients report a decrease in seizures frequency >or=50p.cent, which is usually accepted to classify patients as responders in add on AE drug trials. The objectives of this study based on retrospective analysis of 50 consecutive patients with partial (39) or generalized (11) refractory epilepsy non eligible for surgery were; firstly to evaluate the global long term VNS efficacy and secondly to identify potential predictors of the VNS effects on seizure frequency. No patient has been seizure free at any moment of the follow up (2.8+/-1.8 years, max: 6 years) and the AE has been maintained in all. During follow up 44, 66, 61 and 58p.cent of patients were classified as responders at 6 months, 1, 2 and 3 years, respectively. Logistic regression analysis showed that: the percentage of responders at 6 months of follow up and later was significantly higher than that before 6 months (p=0.002); generalized epilepsy was predictive of a better outcome as compared to partial epilepsy (p=0.03); there was a trend for a better outcome in partial epilepsies symptomatic of a focal lesion than in those with normal brain MRI (p=0.06). These results are in line with previously published data in terms of global efficiency and confirm that seizures control does not reach its maximal level before at least one year of VNS. In severe generalized epilepsies (either secondary or cryptogenic) manifesting by frequent falls due to atonic or tonic-clonic generalized seizures VNS is a useful palliative procedure, which entails much les of surgical risk than callosotomy. The better VNS effects in patients with partial epilepsy possibly reflect the high incidence in our series of Malformations of Cortical Development, which have been identified as one the few variables possibly predictive of a response over 50p.cent of seizures frequency reduction.
迷走神经刺激术(VNS)被认为是控制药物难治性癫痫患者癫痫发作的一种有效方法。它作为一种姑息性手术,作为抗癫痫(AE)药物常规治疗的补充。根据文献报道,40%至50%的患者癫痫发作频率降低≥50%,这通常被认为是在添加AE药物试验中将患者分类为有反应者的标准。本研究基于对50例连续的部分性(39例)或全身性(11例)难治性癫痫且不适合手术的患者进行回顾性分析,其目的:首先是评估VNS的总体长期疗效,其次是确定VNS对癫痫发作频率影响的潜在预测因素。在随访(2.8±1.8年,最长6年)的任何时刻,没有患者无癫痫发作,并且所有患者都持续使用AE药物。在随访期间,分别有44%、66%、61%和58%的患者在6个月、1年、2年和3年时被分类为有反应者。逻辑回归分析表明:随访6个月及以后有反应者的百分比显著高于6个月之前(p = 0.002);与部分性癫痫相比,全身性癫痫预示着更好的结果(p = 0.03);有局灶性病变症状的部分性癫痫比脑MRI正常的部分性癫痫有更好结果的趋势(p = 0.06)。这些结果在总体疗效方面与先前发表的数据一致,并证实癫痫控制在VNS至少一年后才达到最大水平。在因失张力或强直 - 阵挛性全身性癫痫发作而频繁跌倒的严重全身性癫痫(继发性或隐源性)中,VNS是一种有用的姑息性手术,其手术风险比胼胝体切开术小得多。部分性癫痫患者中VNS效果较好可能反映了我们系列中皮质发育畸形的高发生率,皮质发育畸形已被确定为少数可能预测癫痫发作频率降低超过50%反应的变量之一。